South Manganese Investment (HKSE:01091) Other Long-Term Liabilities : HK$348 Mil (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is South Manganese Investment Other Long-Term Liabilities?

South Manganese Investment's other long-term liabilities for the quarter that ended in Dec. 2023 was HK$348 Mil.

South Manganese Investment's quarterly other long-term liabilities declined from Dec. 2022 (HK$351 Mil) to Jun. 2023 (HK$344 Mil) but then increased from Jun. 2023 (HK$344 Mil) to Dec. 2023 (HK$348 Mil).

South Manganese Investment's annual other long-term liabilities increased from Dec. 2021 (HK$308 Mil) to Dec. 2022 (HK$351 Mil) but then declined from Dec. 2022 (HK$351 Mil) to Dec. 2023 (HK$348 Mil).

South Manganese Investment Other Long-Term Liabilities Historical Data

The historical data trend for South Manganese Investment's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

South Manganese Investment Other Long-Term Liabilities Chart

South Manganese Investment Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

South Manganese Investment Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

South Manganese Investment Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

South Manganese Investment Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of South Manganese Investment's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

South Manganese Investment (HKSE:01091) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Metals & Mining » South Manganese Investment Ltd (HKSE:01091) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

00D0:Germany

Address

95 Queensway, Room A02, 35th Floor, United Centre, Admiralty, Hong Kong, HKG

Website

http://www.dameng.citic.com

South Manganese Investment Ltd is a mining company that is engaged in manganese mining and ore processing in China and Gabon and downstream processing operations. It operates in four segments namely Manganese mining which engages in the mining and production of manganese products including mining, beneficiation, concentrating, grinding and the production of manganese concentrates; EMM and alloying materials production segment comprise hydrometallurgical processing and pyrometallurgical processing; Battery materials production segment engages in the production and sale of battery materials products, including Electrolytic Manganese Dioxide; and Trading business segment includes trading of various commodities such as manganese ore, sales of scraps, and others.

Executives

Citic Group Corporation	2201 Interest of corporation controlled by you
Citic Limited	2201 Interest of corporation controlled by you
Sun Mingwen	2201 Interest of corporation controlled by you
Youfu Investment Co., Ltd	2101 Beneficial owner
Feng Xiang Investment Co.,ltd	2101 Beneficial owner
Ma Xuedong	2201 Interest of corporation controlled by you
Gui Nan Da Meng Guo Ji Zi Yuan You Xian Gong Si

South Manganese Investment (HKSE:01091) Headlines

No Headlines